Japan/Sweden: Charles River makes two divestitures

US-based Charles River Laboratories, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions accelerate their research and drug development efforts, has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions. Its RMS Japan operations, which…

You must be a HMI Subscriber to view this content.

Subscribe Now »